Julie Elmer > Freshfields Bruckhaus Deringer LLP > Washington DC, United States > Lawyer Profile
Freshfields Bruckhaus Deringer LLP Offices
700 13TH STREET NW
10TH FLOOR
WASHINGTON, DC 20005
DISTRICT OF COLUMBIA
United States
- Firm Profile
- Go to...
Julie Elmer
Work Department
Antitrust, Competition, and Trade
Position
Partner and US Head of Antitrust
Career
Julie is the US head of antitrust, competition, and trade and a partner in our litigation practice, based in Washington, DC. With over 20 years of civil litigation experience, Julie focuses on US antitrust litigation against both governmental and private plaintiffs; cartel investigations and follow-on civil litigation; and merger and civil conduct investigations before the US Department of Justice, Federal Trade Commission, and State Attorneys General.
Prior to joining Freshfields, Julie served in the Technology and Financial Services section of the DOJ’s Antitrust Division. During her tenure, she became one of the DOJ’s leading trial attorneys, serving as the DOJ’s lead trial counsel in two of the agency’s last three merger challenges, including the Division’s last trial victory in US v. Energy Solutions.
Top Tier Firm Rankings
- M&A/corporate and commercial > Corporate governance
- Dispute resolution > International arbitration
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Tax > Financial products
Firm Rankings
- Dispute resolution > International litigation
- Tax > International tax
- Dispute resolution > M&A litigation: defense
- Dispute resolution > Securities litigation: defense
- Finance > Capital markets: debt offerings
- Finance > Capital markets: equity offerings
- Antitrust > Civil litigation/class actions: defense
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Antitrust > Merger control
- Tax > US taxes: non-contentious
- International trade > CFIUS
- International trade > Customs, export controls and economic sanctions
- Dispute resolution > General commercial disputes
- Media, technology and telecoms > Technology transactions
- Healthcare > Life sciences
- Finance > Commercial lending
- M&A/corporate and commercial > Shareholder activism